Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2024 Sep 27

PMID 39329744

Authors

Biki Saha

Sneha Pallatt

Antara Banerjee

Abhijit G Banerjee

Rupak Pathak

Surajit Pathak

Affiliations

Soon will be listed here.

Abstract

Highly conformal delivery of radiation therapy (RT) has revolutionized the treatment landscape for primary and metastatic liver cancers, yet concerns persist regarding radiation-induced liver disease (RILD). Despite advancements, RILD remains a major dose-limiting factor due to the potential damage to normal liver tissues by therapeutic radiation. The toxicity to normal liver tissues is associated with a multitude of physiological and pathological consequences. RILD unfolds as multifaceted processes, intricately linking various responses, such as DNA damage, oxidative stress, inflammation, cellular senescence, fibrosis, and immune reactions, through multiple signaling pathways. The DNA damage caused by ionizing radiation (IR) is a major contributor to the pathogenesis of RILD. Moreover, current treatment options for RILD are limited, with no established biomarker for early detection. RILD diagnosis often occurs at advanced stages, highlighting the critical need for early biomarkers to adjust treatment strategies and prevent liver failure. This review provides an outline of the diverse molecular and cellular mechanisms responsible for the development of RILD and points out all of the available biomarkers for early detection with the aim of helping clinicians decide on advance treatment strategies from a single literature recourse.

References

Bartesaghi S, Radi R . Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 2017; 14:618-625. PMC: 5694970. DOI: 10.1016/j.redox.2017.09.009. View

Zhao W, Robbins M . Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem. 2009; 16(2):130-43. DOI: 10.2174/092986709787002790. View

Serra M, Marongiu F, Sini M, Marongiu M, Contini A, Wolff H . Hepatocyte senescence induced by radiation and partial hepatectomy in rat liver. Int J Radiat Biol. 2014; 90(10):876-83. DOI: 10.3109/09553002.2014.922714. View

Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D . Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxid Redox Signal. 2013; 20(10):1646-54. PMC: 3942696. DOI: 10.1089/ars.2013.5482. View

Coleman M, Olivier A, Jacobus J, Mapuskar K, Mao G, Martin S . Superoxide mediates acute liver injury in irradiated mice lacking sirtuin 3. Antioxid Redox Signal. 2013; 20(9):1423-35. PMC: 3936509. DOI: 10.1089/ars.2012.5091. View

Barshishat-Kupper M, Tipton A, McCart E, McCue J, Mueller G, Day R . Effect of ionizing radiation on liver protein oxidation and metabolic function in C57BL/6J mice. Int J Radiat Biol. 2014; 90(12):1169-78. DOI: 10.3109/09553002.2014.930536. View

Raza A, Sood G . Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014; 20(15):4115-27. PMC: 3989948. DOI: 10.3748/wjg.v20.i15.4115. View

Bowen S, Chapman T, Borgman J, Miyaoka R, Kinahan P, Liou I . Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients. EJNMMI Res. 2016; 6(1):57. PMC: 4923007. DOI: 10.1186/s13550-016-0212-9. View

Ng S, Jang G, Kurland I, Qiu Y, Guha C, Dawson L . Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy. EBioMedicine. 2020; 59:102973. PMC: 7484529. DOI: 10.1016/j.ebiom.2020.102973. View

10.

Wu Z, Zhang J, Shen X, Zhou L, Gao Y, Hu Y . A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma. Med Phys. 2016; 43(7):4349. DOI: 10.1118/1.4953831. View

11.

Han G, Zhang H, Xie C, Zhou Y . Th2-like immune response in radiation-induced lung fibrosis. Oncol Rep. 2011; 26(2):383-8. DOI: 10.3892/or.2011.1300. View

12.

Zhou L, Wang Z, Gao Y, Wang L, Zeng Z . Stimulation of hepatoma cell invasiveness and metastatic potential by proteins secreted from irradiated nonparenchymal cells. Int J Radiat Oncol Biol Phys. 2012; 84(3):822-8. DOI: 10.1016/j.ijrobp.2012.01.011. View

13.

Liu H, Wang S, Wu Z, Huang Z, Chen W, Yang Y . Glibenclamide, a diabetic drug, prevents acute radiation induced liver injury of mice via up-regulating intracellular ROS and subsequently activating Akt-NF-κB pathway. Oncotarget. 2017; 8(25):40568-40582. PMC: 5522206. DOI: 10.18632/oncotarget.16501. View

14.

Bae B, Yu J, Park H, Goh M, Paik Y . Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017. Radiat Oncol J. 2023; 41(2):98-107. PMC: 10326507. DOI: 10.3857/roj.2023.00353. View

15.

Sinha M, Das D, Manna K, Datta S, Ray T, Sil A . Epicatechin ameliorates ionising radiation-induced oxidative stress in mouse liver. Free Radic Res. 2012; 46(7):842-9. DOI: 10.3109/10715762.2012.684245. View

16.

Martinon F . Signaling by ROS drives inflammasome activation. Eur J Immunol. 2010; 40(3):616-9. DOI: 10.1002/eji.200940168. View

17.

Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T . The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Respir Res. 2013; 14:95. PMC: 3849377. DOI: 10.1186/1465-9921-14-95. View

18.

Blackford A, Jackson S . ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. Mol Cell. 2017; 66(6):801-817. DOI: 10.1016/j.molcel.2017.05.015. View

19.

Cao Y, Wang H, Johnson T, Pan C, Hussain H, Balter J . Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2012; 85(1):258-63. PMC: 3629546. DOI: 10.1016/j.ijrobp.2012.02.037. View

20.

Liang S, Zhu X, Xu Z, Zhu J, Zhao J, Lu H . Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006; 65(2):426-34. DOI: 10.1016/j.ijrobp.2005.12.031. View